← Leaderboards
Alan D. Snow
Proteotech, Inc.
$8,105,822
Attributed
$8,105,822
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$8,105,822 · 9
By mechanism
R44$6,276,924 · 5
R43$1,828,898 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Amyloid Proteins”
- Paul S. Aisen · Cognition Therapeutics, Inc.$179,155,785
- Randall J Bateman · Washington University$159,348,765
- Reisa A. Sperling · Banner Health$126,841,626
- Eric Martin McDade · Washington University$96,859,497
- Keith A. Johnson · Banner Health$76,689,590
- Michael W Weiner · Northern California Institute Res &Educ$76,647,673
Research focus
Amyloid ProteinsAmyloidosisAlzheimer'S DiseaseScreening ProcedureMouse ModelPharmaceutical PreparationsIn VitroFibrillogenesisBrainInhibitor/AntagonistDisease /Disorder ModelAmyloidDesignNovel TherapeuticsDepositionBiochemicalAlzheimer&AposDrug KineticsFluorometryLeadImage AnalysisAnimal ModelBaseSmall Business Innovation Research Grant
Grant awards (17)
Tau Protein Aggregation Inhibitors for Tauopathies$1,081,413
R44 · FY2013 · AG · contact PI
Identification of Novel Small Molecules as Tau Protein Aggregation Inhibitors for$770,675
R43 · FY2011 · AG · contact PI
Systemic AA Amyloidosis Inhibitors$390,262
R44 · FY2010 · AR · contact PI
Systemic AA Amyloidosis Inhibitors$519,410
R44 · FY2009 · AR · contact PI
Laminin-Derived Protein Fragments as Inhibitors of Alzheimer's Amyloidosis$516,960
R44 · FY2008 · AG · contact PI
Systemic AA Amyloidosis Inhibitors$420,791
R44 · FY2008 · AR · contact PI
Laminin-Derived Protein Fragments as Inhibitors of Alzheimer's Amyloidosis$822,374
R44 · FY2007 · AG · contact PI
Laminin-Derived Protein Fragments as Inhibitors of Alzheimer's Amyloidosis$948,839
R44 · FY2006 · AG · contact PI
Amyloid Inhibiting Agent for Treatment of Alzheimer's$100,000
R44 · FY2005 · AG
Proteoglycans/Glycosaminoglycans in APP Transgenic Mice$520,841
R43 · FY2004 · AG
Systemic AA Amyloidosis Inhibitors$264,984
R43 · FY2004 · AR
Inhibitors of Alzheimer's Disease Amyloidosis$97,426
R44 · FY2004 · AG
Alzheimer's Amyloid Plaque Persistence In Vivo$217,868
R44 · FY2003 · AG
Amyloid Inhibiting Agent for Treatment of Alzheimer's$185,111
R44 · FY2003 · AG
Alzheimer's Amyloid Plaque Persistence In Vivo$491,293
R44 · FY2002 · AG
Alzheimer's Amyloid Plaque Persistence In Vivo$485,177
R44 · FY2001 · AG
ALZHEIMER'S AMYLOID PLAQUE PERSISTENCE IN VIVO$272,398
R43 · FY2000 · AG